Deep Medicine Acquisition Corp.
NASDAQ: DMAQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Humphrey P. Polanen
- Employees
- 2
- Headquarters
- New York City, United States
- IPO year
- 2021
- Market cap
- $12.9M
Loading DMAQ…
Loading profile data…Frequently asked questions about DMAQ
What does Deep Medicine Acquisition Corp. (DMAQ) do?
Deep Medicine Acquisition Corp. (DMAQ) currently operates as a non-operating entity, possessing no substantial business functions of its own. Its express purpose is to execute a business combination, which could entail a merger, an acquisition of equity or assets, or a reorganization, with one or more target companies. The firm's strategic effor...
Where does DMAQ trade?
Deep Medicine Acquisition Corp. (DMAQ) trades on the NASDAQ Global Market.
What sector is DMAQ in?
Deep Medicine Acquisition Corp. (DMAQ) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Deep Medicine Acquisition Corp.?
Humphrey P. Polanen is the chief executive officer of Deep Medicine Acquisition Corp. (DMAQ).
Where is Deep Medicine Acquisition Corp. headquartered?
Deep Medicine Acquisition Corp. is headquartered in United States.
Does DMAQ pay a dividend?
Deep Medicine Acquisition Corp. (DMAQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DMAQ go public?
Deep Medicine Acquisition Corp. (DMAQ) completed its initial public offering in 2021.